SAN ANTONIO, TX / ACCESS Newswire / October 14, 2026 / Valion Bio, Inc. (NASDAQ: VBIO) ("Valion" or the "Company"), a clinical-stage ...
News
- With Section 232 Tariffs Reshaping Biotech, Valion Bio's Velocity Bioworks Capitalizes on ...
- UT San Antonio study finds endometrial cancer rates highest in San Antonio region
UT San Antonio study finds endometrial cancer rates highest in San Antonio region ... biomedical sciences and public health that are leading ...
- With Section 232 Tariffs Reshaping Biotech, Valion Bio's Velocity Bioworks Capitalizes on ...
Velocity Bioworks' San Antonio facility offers process development, analytical services, and early-phase clinical drug substance manufacturing for ...
- Generate Biomedicines, Zealand Pharma Strike $1.2B Deal - Hoodline
The company went public on Nasdaq in February, a milestone Hoodline covered in its piece on the Somerville biotech's ... SAN ANTONIO SAN DIEGO SAN ...
- Jaguar Promise Expands Access to Higher Education at A&M-San Antonio - StreetInsider
SAN ANTONIO , Oct. 14, 2026 /PRNewswire/ -- As Texas A&M University-San ... The University will also introduce a Bachelor of Science in Biomedical ...